相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Highly Discriminating Photorelease of Anticancer Drugs Based on Hypoxia Activatable Phototrigger Conjugated Chitosan Nanoparticles
Qiuning Lin et al.
ADVANCED MATERIALS (2013)
Development of Azo-Based Fluorescent Probes to Detect Different Levels of Hypoxia
Wen Piao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
PEG-sheddable polyplex micelles as smart gene carriers based on MMP-cleavable peptide-linked block copolymers
Junjie Li et al.
CHEMICAL COMMUNICATIONS (2013)
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies
Glen J. Weiss et al.
INVESTIGATIONAL NEW DRUGS (2013)
Determination of key structure-activity relationships in siRNA delivery with a mixed micelle system
Marta Omedes Pujol et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment
Claudine Kieda et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Sheddable Ternary Nanoparticles for Tumor Acidity-Targeted siRNA Delivery
Xian-Zhu Yang et al.
ACS NANO (2012)
Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery
Rupa R. Sawant et al.
BIOMATERIALS (2012)
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Geeta Mehta et al.
JOURNAL OF CONTROLLED RELEASE (2012)
P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells
Gemma Navarro et al.
NANOMEDICINE (2012)
Hypoxia-activated prodrugs forge ahead in cancer
Jim Kling
NATURE BIOTECHNOLOGY (2012)
My love (of nanoparticles) is like an onion: novel layered - nanovehicle developed for tumor targeting
[Anonymous]
THERAPEUTIC DELIVERY (2011)
In Vivo Delivery of RNAi with Lipid-Based Nanoparticles
Leaf Huang et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13 (2011)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Paclitaxel Tumor-Priming Enhances siRNA Delivery and Transfection in 3-Dimensional Tumor Cultures
Ho Lun Wong et al.
MOLECULAR PHARMACEUTICS (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Layer-by-Layer Nanoparticles with a pH-Sheddable Layer for in Vivo Targeting of Tumor Hypoxia
Zhiyong Poon et al.
ACS NANO (2011)
Electrochemical cleavage of azo linkage for site-selective immobilization and cell patterning
Hyun Joo Jung et al.
CHEMICAL COMMUNICATIONS (2010)
Hypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute Ischemia
Kazuki Kiyose et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Significance of nitroimidazole compounds and hypoxia-inducible factor-1 for imaging tumor hypoxia
Shinae Kizaka-Kondoh et al.
CANCER SCIENCE (2009)
Extracellular barriers to in Vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver
Rob S. Burke et al.
BIOCONJUGATE CHEMISTRY (2008)
PEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacy
Anastasia Malek et al.
JOURNAL OF DRUG TARGETING (2008)
Molecular imaging of hypoxia
Kenneth A. Krohn et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors
Seiji Takae et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H. Hatakeyama et al.
GENE THERAPY (2007)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells
T Ishida et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)